Practice parameters for the management of single brain metastasis

Neurosurgical Focus - Tập 9 Số 6 - Trang 1-9 - 2000
Jack Rock1, John A. Washington1, Lawrence D. Recht1, Megan Bernstein1, Raymond Sawaya1, Tom Mikkelsen1, Jay S. Loeffler1
1Henry Ford Health System

Tóm tắt

Object In January 1998 the Guidelines and Outcomes Committee of the American Association of Neurological Surgeons (AANS) issued a charge for the development of evidence-based practice parameters focusing on the treatment of patients with single metastasis to the brain. The charge was imposed in response to the significant controversy surrounding questions relating to the optimal management strategies for patients with single brain metastasis. Methods A team consisting of physicians from the AANS, the American Academy of Neurology, and the American Association of Therapeutic Radiation Oncology convened and the literature was reviewed. Methodically drawing from the best of Class I, II, and III levels of available evidence, authors sought to determine how the literature addressed and disposed of the question of the optimal management for an adult with a known history of cancer and a single meta-static brain lesion. Framing the question in this specific manner allowed researchers to focus directly on treatment issues, without having to consider diagnostic issues. Conclusions The results of the evidence-based analysis demonstrated that there was insufficient information to establish standards of care. Data from the literature does, however, support a guideline stating that surgical resection accompanied by whole brain radiation therapy is associated with the best survival rate. Additional lower-quality evidence supports an option for management with radiosurgery.

Từ khóa


Tài liệu tham khảo

10.1093/jnci/87.1.34

10.1007/BF01420299

Armstrong JG, 1994, J Clin Oncol, 12, 2234, 10.1200/JCO.1994.12.11.2340

10.1016/S0360-3016(96)85008-5

10.1016/0090-4295(90)80208-5

10.3171/jns.1996.84.5.0748

10.3171/jns.1993.79.2.0210

10.1002/1097-0142(19901115)66:10<2105::AID-CNCR2820661011>3.0.CO;2-I

Burt M, 1992, J Thorac Cardiovasc Surg, 103, 399, 10.1016/S0022-5223(19)34977-3

10.1007/BF00165714

Coffey RJ, 1991, Acta Neurosurg, 52, 90

10.1097/00006123-198906000-00002

Decker DA, 1984, J Clin Oncol, 2, 169, 10.1200/JCO.1984.2.3.169

10.3109/02688698909001029

10.1016/0360-3016(80)90260-6

10.1001/jama.263.22.3077

10.1002/1097-0142(19930215)71:4<1353::AID-CNCR2820710430>3.0.CO;2-6

10.1002/1097-0142(19930215)71:4<1362::AID-CNCR2820710431>3.0.CO;2-5

10.1002/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H

10.1097/00006123-198009000-00006

10.1002/(SICI)1520-6823(1997)5:1<31::AID-ROI5>3.0.CO;2-L

Ferrara M, 1990, J Neurosurg Sci, 34, 303

10.1016/0360-3016(94)90098-1

10.1002/1097-0142(19800115)45:2<381::AID-CNCR2820450232>3.0.CO;2-J

10.1002/1097-0142(19801101)46:9<2088::AID-CNCR2820460929>3.0.CO;2-4

Hagen NA, 1990, Neurology, 40, 158, 10.1212/WNL.40.1.158

10.1016/S0003-4975(10)65846-8

Hazuka MB, 1993, J Clin Oncol, 11, 369, 10.1200/JCO.1993.11.2.369

10.1016/0167-8140(95)01691-0

Joseph J, 1996, J Clin Oncol, 14, 1085, 10.1200/JCO.1996.14.4.1085

10.1016/0360-3016(81)90006-7

10.1227/00006123-198801000-00002

10.1097/00000421-199704000-00003

Kreth FW, 1993, Acta Neurochir, 58, 112

Leavens ME, 1986, Bull Cancer, 38, 39

10.1002/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B

10.1016/S0003-4975(10)60536-X

Mandell L, 1986, Cancer, 58, 641, 10.1002/1097-0142(19860801)58:3<641::AID-CNCR2820580308>3.0.CO;2-4

10.1002/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X

10.1016/S0360-3016(97)00341-6

10.1016/S0022-5223(96)70190-3

10.1136/jnnp.57.8.950

10.1016/0360-3016(94)90558-4

10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U

Oredsson S, 1990, Eur J Surg Oncol, 16, 451

Patchell RA, 1986, Neurology, 36, 447, 10.1212/WNL.36.4.447

10.1001/jama.280.17.1485

10.1056/NEJM199002223220802

10.1016/0360-3016(95)00168-X

Posner JB, 1977, Semin Oncol, 4, 81

Posner JB, 1978, Adv Neurol, 19, 579

10.1002/1097-0142(19890215)63:4<657::AID-CNCR2820630410>3.0.CO;2-Q

Read RC, 1989, J Thorac Cardiovasc Surg, 98, 884, 10.1016/S0022-5223(19)34267-9

10.1007/BF00314834

10.3171/jns.1998.88.1.0011

10.1097/00000421-199010000-00013

Sause WT, 1993, Int J Radiat Oncol Biol Phys, 26, 653, 10.1016/0360-3016(93)90284-3

10.1016/S0360-3016(96)00488-9

10.1007/BF02305789

10.3171/jns.1992.77.4.0531

10.1016/0360-3016(87)90154-4

10.1016/S0360-3016(96)00347-1

Stevens G, 1992, Radiother Oncol, 23, 185, 10.1016/0167-8140(92)90329-S

Sturm V, 1991, Stereotact Funct Neurosurg, 5, 717

10.1002/1097-0142(19850315)55:6<1382::AID-CNCR2820550637>3.0.CO;2-Z

10.2176/nmc.36.364

10.1002/ana.410330605

10.1007/BF00346606

White KT, 1981, Mayo Clin Proc, 56, 424

10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-O

10.3171/jns.1995.83.4.0605

10.1002/(SICI)1097-0142(19971101)80:9<1746::AID-CNCR8>3.0.CO;2-C

10.1016/S0360-3016(97)00006-0

10.1016/0090-3019(84)90118-6

10.1016/0360-3016(86)90327-5

10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8